Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure.

Keywords

Derecho, Political science, Medicine, Philosophy, Humanities

References

• Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac.Michael Stonebraker — 2002
• Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group.Elliot Ehrich, Thomas J. Schnitzer, Harris McIlwain — 1999
• Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?Gastone Leonetti, Cesare Cuspidi, M. Facchini — 2000
• A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]Eduardo Collantes‐Estévez, Sean Curtis, Ka Wing Lee — 2002
• A clinical audit of the prescribing of celecoxib and rofecoxib in Australian rural general practice.Christopher Cutts, Adam La Caze, Susan E. Tett — 2002
• A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.Alan K. Matsumoto, Agustin Melian, David R. Mandel — 2002
• Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-AnalysisAnthony G. Johnson, Tuan V. Nguyen, Richard O. Day — 1994
• Evaluation of cyclooxygenase 2 inhibitor use in patients admitted to a large teaching hospitalP. G. Landsberg, Peter I. Pillans, James M Radford — 2003
• The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group.Thomas J. Schnitzer, K. E. Truitt, Roy Fleischmann — 1999
• Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM StatementQUOROM Group, David Moher, Deborah J Cook — 1999
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.Aram V. Chobanian, George L. Bakris, Henry R. Black — 2003
• Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.Grant W. Cannon, Jacques R. Caldwell, Peter R. Holt — 2000
• Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.Reva C. Lawrence, Charles G. Helmick, Frank C. Arnett — 1998
• Cyclooxygenase-2–Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis PatientsAndrew Whelton, John G. Fort, Joseph A. Puma — 2001
• Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).Thomas D. Penning, John J. Talley, Stephen R. Bertenshaw — 1997
• Complementary studies of the gastrointestinal safety of the cyclo‐oxygenase‐2‐selective inhibitor etoricoxibRichard H. Hunt, S. E. Harper, P. Callegari — 2003
• Strengths and limitations of meta-analysis: larger studies may be more reliable.Marcus Flather, Michael E. Farkouh, Janice Pogue — 1997
• Fifty years of Framingham Study contributions to understanding hypertensionKannel Wb — 2000
• Nonsteroidal anti-inflammatory drugs and antihypertensives.Mark C. Houston — 1991
• A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure.Janet Pope — 1993

Cited by

• Introduction — The coxib controversiesFrancisco Javier Vallina Samperio — 2005
• Cardiovascular Comorbidity in Rheumatic Diseases A Focus on Heart FailureKerry Wright, Cynthia S. Crowson, Sherine E. Gabriel — 2014
• ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.António Cerveira Pinto — 2011
• [Efficacy of the combined treatment with artrosan and combilipen in patients with acute low-back pain].T. T. Batysheva, O. V. Otcheskaia, A. A. Khozova — 2011
• Coxibs and heart disease: what we have learned and what else we need to know.Ignatius Gerardo E. Zarraga, Ernst R. Schwarz — 2007
• Cardiovascular effects of cyclooxygenase-2 inhibitorsJames M. Brophy — 2007
• What We Have Learned and What Else We Need to KnowIgnatius Gerardo, E. Zarraga, Ernst R. Schwarz — 2007
• Variability in the Response to Cyclooxygenase InhibitorsTilo Großer — 2009
• Prostaglandins in action indispensable roles of cyclooxygenase-1 and -2 in endothelium-dependent contractions.Siu Ling Wong, Wing Tak Wong, Xiao Yu Tian — 2010
• NSAIDs and cardiovascular riskFabio Marsico, Stefania Paolillo, Pasquale Perrone Filardi — 2017
• Pharmacological Management of Persistent Pain in Older PersonsElvy Ickowicz — 2009
• Réduction des dommages myocardiques par le célécoxib suite à une ischémie transitoire chez le ratLaura Lada-Moldovan — 2010
• Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and MiceYuling Chi, Jean-François Jasmin, Yoshinori Seki — 2015
• Inclusion of Safety Pharmacology Endpoints in Repeat-Dose Toxicity Studies.Will S. Redfern — 2015
• Celecoxib does not alter cardiovascular and renal function during dietary salt loadingMegan M. Wenner, David G. Edwards, Chester A. Ray — 2011
• Vascular KCNQ Potassium Channels as Therapeutic Targets in Cerebral VasospasmBharath K. Mani, Lioubov I. Brueggemann, Kenneth L. Byron — 2010
• Pharmacological management of persistent pain in older persons.2009
• Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines.Timothy Pham, Michael J. Miller, Donald L. Harrison — 2013
• Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritisCore Journal — 2007
• Особенности лечения суставного синдрома у лиц пожилого возраста с артериальной гипертензиейИ В Егоров, V V Tsurko, И В Егоров — 2008

Related papers

No related papers recorded.